Unlikely new problem emerges for immunotherapy trials – The Pharma Letter (registration)
The Pharma Letter (registration) |
Unlikely new problem emerges for immunotherapy trials
The Pharma Letter (registration) Given the prevalence of cancer, not having enough patients to test the potential cancer treatments of tomorrow might seem an unlikely problem. But according to The Financial Times, pharma execs are concerned that some companies might struggle to fill … |
